On October 30, 2020, Natco Pharma Limited received approval from the FDA for its generic version of the oral drug pomalidomide under ANDA210111, a mov...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Accord Healthcare Inc. has received FDA approval for the Abbreviated New Drug Application (ANDA207991) for oral fingolimod hydrochloride, introducing ...
FDA has granted tentative approval to Accord Healthcare, Inc.’s ANDA for methylphenidate hydrochloride tablets, a generic version of the drug known by...
Leading Pharma, LLC received FDA approval for generic oral Leucovorin Calcium, introducing a new entrant that is expected to intensify competition and...
The FDA’s approval of Gilead Sciences, Inc.’s intravenous remdesivir (VEKLURY) marks a significant milestone for the company’s antiviral portfolio, po...
# FDA Approves Harmony Biosciences' WAKIX for Narcolepsy Treatment Harmony Biosciences announced FDA approval of WAKIX (pitolisant hydrochloride), an...
# FDA Approves Lifestar Pharma's Generic Acetazolamide The U.S. Food and Drug Administration has approved Lifestar Pharma LLC's abbreviated new drug ...
SpecGx LLC has secured FDA approval for the generic oral formulation of Diphenoxylate Hydrochloride and Atropine Sulfate, positioning the company to e...
Pfizer’s FDA approval of XELJANZ reinforces its competitive position in the rheumatology market, expected to drive incremental sales growth as it capt...
Avet Pharmaceuticals Inc. announced FDA approval of its Abbreviated New Drug Application for oral acyclovir, potentially strengthening its position in...
Granules Pharmaceuticals Inc. received approval for its ANDA 213813 to manufacture and market Dexmethylphenidate Hydrochloride, the active ingredient ...
Hikma Pharmaceuticals USA Inc. announced the approval of its generic fosaprepitant dimeglumine intravenous injection by the FDA, a motion sickness ant...
# FDA Approves Celgene's ONUREG (Azacitidine) as First Oral Maintenance Therapy for AML The FDA approval of Celgene Corporation's ONUREG (azacitidine...
TruPharma, LLC announced on Monday the implementation of the 180-day generic exclusivity period for its 50 mg and 100 mg oral tramadol hydrochloride t...
Accord Healthcare announced FDA approval for a new drug application on Aug. 24, 2020, which market analysts expect to broaden the company’s product po...
# FDA Approves Generic Gabapentin from Zhejiang Yongtai Pharmaceutical The U.S. Food and Drug Administration has approved Zhejiang Yongtai Pharmaceut...
# FDA Approves Genentech's ENSPRYNG for Neuromyelitis Optica Spectrum Disorder The FDA has approved Genentech's ENSPRYNG (satralizumab), a subcutaneo...
# FDA Approves Genentech's EVRYSDI (risdiplam) for Spinal Muscular Atrophy Genentech announced FDA approval of EVRYSDI (risdiplam), an oral treatment...
Astellas Pharma Inc. received FDA approval for its oral androgen receptor antagonist Enzalutamide, assigned the brand name XTANDI, to treat certain me...
Concord Biotech Limited won approval for its ANDA212087 on July 31, 2020, for the oral product Mycophenolate Mofetil, indicating the company is positi...